Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8433611 | Cancer Genetics | 2018 | 7 Pages |
Abstract
Colorectal cancer associated transcript 1 (CCAT1) is a novel long noncoding RNA, whose overexpression is evident in both early phase of tumorigenesis and later disease stages in colorectal cancer (CRC). No study has explored the relationship between CCAT1 polymorphisms and CRC risk. In the present study, a case-control study was conducted to investigate the association between CCAT1 polymorphisms and CRC risk in Chinese population. We identified that CCAT1 rs67085638 polymorphism was associated with an increased risk of CRC (ORâ¯=â¯1.72, 95%CIâ¯=â¯1.14-2.58, Pâ¯=â¯0.009 in heterozygote codominant model; ORâ¯=â¯1.67, 95%CIâ¯=â¯1.13-2.47, Pâ¯=â¯0.010 in dominant model). Moreover, CCAT1 rs7013433 polymorphism was associated with late clinical stage (ORâ¯=â¯1.82, 95%CIâ¯=â¯1.16-2.86, Pâ¯=â¯0.009 in heterozygote codominant model; ORâ¯=â¯1.72, 95%CIâ¯=â¯1.13-2.63, Pâ¯=â¯0.012 in dominant model). Our finding proposed a link between CCAT1 polymorphisms with CRC risk as well as different clinical stages.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yingjun Li, Fangyuan Jing, Ye Ding, Qingfang He, Yaohong Zhong, Chunhong Fan,